Janney Montgomery Scott’s CorMedix CRMD Stock Holding History

Janney Montgomery Scott’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$78K	Sell	10,000 -6,998	-41%	-$55.3K	﹤0.01%	3074
2026 Q1	$115K	Sell	16,998 -86,302	-84%	-$638K	﹤0.01%	2694
2025 Q4	$1.2M	Buy	103,300 +13,130	+15%	+$145K	﹤0.01%	1630
2025 Q3	$1.05M	Buy	90,170 +80,170	+802%	+$969K	﹤0.01%	1663
2025 Q2	$123K	Hold	10,000	–	–	﹤0.01%	2625
2025 Q1	$62K	Hold	10,000	–	–	﹤0.01%	2632
2024 Q4	$81K	Buy	+10,000	New	+$99.9K	﹤0.01%	2643

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Janney Montgomery Scott's CRMD Position: Q2 2026 in Review

Janney Montgomery Scott reduced its CorMedix (CRMD) stake by 41% in Q2 2026, selling an estimated $55.3K and leaving 10,000 shares worth $78K. The position accounts for ﹤0.01% of the portfolio, ranked #3074.

Janney Montgomery Scott first reported a position in CRMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.2M in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Janney Montgomery Scott held 10,000 shares of CorMedix worth $78K as of Q2 2026.
Janney Montgomery Scott sold 6,998 CorMedix shares in Q2 2026, an estimated $55.3K.
CorMedix made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #3074 holding.
Janney Montgomery Scott first reported a position in CorMedix in Q4 2024 and has held it in 7 quarters since.
Janney Montgomery Scott's CorMedix position peaked at $1.2M in Q4 2025.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.